| dc.date.accessioned | 2020-05-21T15:36:20Z | |
| dc.date.available | 2020-05-21T15:36:20Z | |
| dc.date.issued | 2020-05-20 | |
| dc.identifier.citation | Health Protection Surveillance Centre, 'COVID-19 : interim FAQs for the interpretation and subsequent action related to repeat testing, V1.0 20/05/2020', [other], Health Protection Surveillance Centre, 2020-05-20 | en |
| dc.description | These FAQs are based on the evidence reviews by HIQA which informed the COVID-19 Expert Advisory group (EAG) decisions. Note: this guidance is interim and will be updated as the situation changes and new evidence emerges. It is also important that risk assessments and clinical judgement are employed. | en |
| dc.language.iso | en | en |
| dc.publisher | Health Protection Surveillance Centre | en |
| dc.rights | Y | en |
| dc.subject | Covid-19 | en |
| dc.subject | Coronavirus | en |
| dc.subject | Assessment and testing pathways | en |
| dc.title | COVID-19 : interim FAQs for the interpretation and subsequent action related to repeat testing, V1.0 20/05/2020 | en |
| dc.type | other | en |
| dc.type.supercollection | edepositireland | |
| dc.contributor.corporatename | Health Protection Surveillance Centre | en |
| dc.publisher.place | ireland | en |
| dc.description.version | Version 1.0 | en |
| dc.rights.ecaccessrights | openAccess | |
| dc.relation.relatedto | TCD Covid-19 Collection | |
| dc.identifier.uri | http://hdl.handle.net/2262/92639 | |
